Aphria Partners With International Consumer Lifestyle Brand Tokyo Smoke

Aphria announced in a press release yesterday, a groundbreaking licensing deal with the premium lifestyle brand Tokyo Smoke.  The partnership allows Aphria to ship Tokyo Smoke branded cannabis to registered patients across Canada. This partnership is indicative of the major changes coming to Canada with pending legalization, as Tokyo Smoke joins forces with a Canadian licensed producer to build out the future of marijuana brands operating in Canada.  Tokyo Smoke worked closely with Aphria to handpick four strains which Aphria will grow at it's licensed facility in Leamington, Ontario.

"Aphria is one of the most trusted producers of medical cannabis, and this partnership with Tokyo Smoke affirms our commitment to expand and diversify our product offering and market channels," said Vic Neufeld, Chief Executive Officer of Aphria. "When cannabis is legalized for recreational use in Canada, a strong brand will be one of the key differentiators for patients and consumers, and we're committed to working with Tokyo Smoke to be the first premium cannabis brand in Canada."

"Tokyo Smoke is an award-winning lifestyle brand that brings sophistication and design to coffee, clothing and cannabis. Each vertical of the brand is designed around four emotive states, which tie together the coffee, cannabis strains, and clothing. Tokyo Smoke worked alongside of Aphria to handpick its strain offerings and Aphria will grow and prepare Tokyo Smoke's four proprietary cannabis experiences at its licensed facility in Leamington, Ontario.

Tokyo Smoke says each of the four strains are based on the following emotive states:

Go - an energizing, awakening sativa;
Relax - an easing indica;
Relief - a soothing cannabidiol;
Balance - a blissful, even hybrid.

"This licensing deal represents the next big step in Tokyo Smoke's vision to elevate the cannabis experience in Canada and we're beyond excited to be partnering with Aphria, a top Canadian grower, to bring our product to the mainstream medical market," said Alan Gertner, Chief Executive Officer of Tokyo Smoke. "With this groundbreaking deal, we're giving Canadians a glimpse into the future of cannabis in the country, proving that two brands can come together to offer consumers increased choice and quality."